Fair Value Measurements And Financial Instruments Fair Value Inputs, Liabilities, Quantitative Information (Details) (Significant Unobservable Inputs (Level 3) [Member], USD $) In Millions, unless otherwise specified								3 Months Ended			3 Months Ended
	Mar. 29, 2014 Contingent Consideration Liability [Member]	Dec. 28, 2013 Contingent Consideration Liability [Member]	Mar. 29, 2014 Endosense S.A. [Member] Contingent Consideration Liability [Member]	Dec. 28, 2013 Endosense S.A. [Member] Contingent Consideration Liability [Member]	Mar. 29, 2014 Nanostim [Member] Contingent Consideration Liability [Member]	Dec. 28, 2013 Nanostim [Member] Contingent Consideration Liability [Member]	Mar. 29, 2014 Endosense S.A. [Member]	Mar. 29, 2014 Endosense S.A. [Member] Minimum [Member]	Mar. 29, 2014 Endosense S.A. [Member] Maximum [Member]	Mar. 29, 2014 Endosense S.A. [Member] Contingent Consideration Liability [Member]	Mar. 29, 2014 Nanostim [Member]	Mar. 29, 2014 Nanostim [Member] Contingent Consideration Liability [Member]	Mar. 29, 2014 Payment Year 1 [Member] Nanostim [Member]	Mar. 29, 2014 Payment Year 2 [Member] Nanostim [Member]	Mar. 29, 2014 Payment Year 3 [Member] Nanostim [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Contingent consideration	$ 198	$ 195	$ 141	$ 139	$ 57	$ 56				$ 141		$ 57
Fair Value Inputs, Discount Rate								1.15%	1.59%		5.00%
Probability of Payment							90.00%				100.00%
Projected Year Of Payment							2014						2016	2017	2018